New insights into the human metabolism of the Fusarium mycotoxins deoxynivalenol and zearalenone

Toxicology Letters

Volumn 220, Issue 1, 2013, Pages 88-94

  Warth, Benedikt ^a   Sulyok, Michael ^a   Berthiller, Franz ^a   Schuhmacher, Rainer ^a   Krska, Rudolf ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Biomarker; Glucuronide; Mycotoxin; Phase II metabolism; Toxicokinetics

Indexed keywords

GLUCURONIDE; MYCOTOXIN; VOMITOXIN; ZEARALENONE;

ADULT; ARTICLE; CASE REPORT; CONJUGATION; FOOD CONTAMINATION; FOOD SAFETY; FUSARIUM; HUMAN; IN VIVO STUDY; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; URINALYSIS; URINARY EXCRETION;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FOOD CONTAMINATION; FOOD MICROBIOLOGY; FUSARIUM; GLUCURONIDES; HUMANS; MALE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TIME FACTORS; TRICHOTHECENES; ZEARALENONE;

EID: 84877329386     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.04.012     Document Type: Article

References (42)

1. Bandera E.V., Chandran U., Buckley B., Lin Y., Isukapalli S., Marshall I., King M., Zarbl H. Urinary mycoestrogens, body size and breast development in New Jersey girls. Science of the Total Environment 2011, 409:5221-5227.
2. Berthiller F., Crews C., Dall'Asta C., Saeger S.D., Haesaert G., Karlovsky P., Oswald I.P., Seefelder W., Speijers G., Stroka J. Masked mycotoxins: a review. Molecular Nutrition and Food Research 2013, 57:165-186.
3. Berthiller F., Krska R., Domig K.J., Kneifel W., Juge N., Schuhmacher R., Adam G. Hydrolytic fate of deoxynivalenol-3-glucoside during digestion. Toxicology Letters 2011, 206:264-267.
4. CAST, Council for Agricultural Science and Technology, 2003. Mycotoxins: risks in plant animal and human systems. Task Force Report No 139, Ames, Iowa.
5. Côté L.M., Dahlem A.M., Yoshizawa T., Swanson S.P., Buck W.B. Excretion of deoxynivalenol and its metabolite in milk, urine, and feces of lactating dairy cows. Journal of Dairy Science 1986, 69:2416-2423.
6. Dall'Erta A., Cirlini M., Dall'Asta M., Del Rio D., Galaverna G., Dall'Asta C. Masked mycotoxins are efficiently hydrolyzed by human colonic microbiota releasing their aglycones. Chemical Research in Toxicology 2013, 26:305-312.
7. Dänicke S., Swiech E., Buraczewska L., Ueberschär K.H. Kinetics and metabolism of zearalenone in young female pigs. Journal of Animal Physiology and Animal Nutrition 2005, 89:268-276.
8. Eriksen G.S., Pettersson H., Lindberg J.E. Absorption, metabolism and excretion of 3-acetyl don in pigs. Archives of Animal Nutrition 2003, 57:335-345.
9. European Commission, 2006. Commission Regulation (EC) No 1881/2006 of 19 December 2006 setting maximum levels for certain contaminants in foodstuffs (consolidated version 2010-07-01). Official Journal of the European Union.
10. FAO/WHO WHO food additives series 44. Presented at the 53rd Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA) Zearalenone 2000.
11. FAO/WHO WHO food additives series 47. Presented at the 56th Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). FAO Food Nutrition Paper, Volume 74 2001.
12. FAO/WHO, 2010. Summary Report of the 72nd Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA).
13. Fitzpatrick D.W., Arbuckle L.D., Hassen A.M. Zearalenone metabolism and excretion in the rat: effect of different doses. Journal of Environmental Science and Health B 1988, 23:343-354.
14. Fruhmann P., Warth B., Hametner C., Berthiller F., Horkel E., Adam G., Sulyok M., Krska R., Fröhlich J. Synthesis of deoxynivalenol-3-ß-d-O-glucuronide for its use as biomarker for dietary deoxynivalenol exposure. World Mycotoxin Journal 2012, 5:127-132.
15. Gratz S.W., Duncan G., Richardson A.J. The human fecal microbiota metabolizes deoxynivalenol and deoxynivalenol-3-glucoside and may be responsible for urinary deepoxy-deoxynivalenol. Applied and Environment Microbiology 2013, 79:1821-1825.
16. Lake B.G., Phillips J.C., Walters D.G. Studies on the metabolism of deoxynivalenol in the rat. Food and Chemical Toxicology 1987, 25:589-592.
17. Lattanzio V.M.T., Solfrizzo M., De Girolamo A., Chulze S.N., Torres A.M., Visconti A. LC-MS/MS characterization of the urinary excretion profile of the mycotoxin deoxynivalenol in human and rat. Journal of Chromatography B 2011, 879:707-715.
18. Massart F., Meucci V., Saggese G., Soldani G. High growth rate of girls with precocious puberty exposed to estrogenic mycotoxins. Journal of Pediatrics 2008, 152:690-695.
19. Maul R., Warth B., Kant J.-S., Schebb N.H., Krska R., Koch M., Sulyok M. Investigation of the hepatic glucuronidation pattern of the Fusarium mycotoxin deoxynivalenol in various species. Chemical Research in Toxicology 2012, 25:2715-2717.
20. Meky F.A., Turner P.C., Ashcroft A.E., Miller J.D., Qiao Y.L., Roth M.J., Wild C.P. Development of a urinary biomarker of human exposure to deoxynivalenol. Food and Chemical Toxicology 2003, 41:265-273.
21. Metzler M., Pfeiffer E., Hildebrand A.A. Zearalenone and its metabolites as endocrine disrupting chemicals. World Mycotoxin Journal 2010, 3:385-401.
22. Mikula H., Hametner C., Berthiller F., Warth B., Krska R., Adam G., Fröhlich J. Fast and reproducible chemical synthesis of zearalenone-14-β,d-glucuronide. World Mycotoxin Journal 2012, 5:289-296.
23. Mirocha C.J., Pathre S.V., Robison T.S. Comparative metabolism of zearalenone and transmission into bovine milk. Food and Cosmetics Toxicology 1981, 19:25-30.
24. Nagl V., Schwartz H., Krska R., Moll W.D., Knasmüller S., Ritzmann M., Adam G., Berthiller F. Metabolism of the masked mycotoxin deoxynivalenol-3-glucoside in rats. Toxicology Letters 2012, 213:367-373.
25. Pestka J. Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance. Archives of Toxicology 2010, 84:663-679.
26. Pestka J.J. Toxicological mechanisms and potential health effects of deoxynivalenol and nivalenol. World Mycotoxin Journal 2010, 3:323-347.
27. Pfeiffer E., Hildebrand A., Mikula H., Metzler M. Glucuronidation of zearalenone, zeranol and four metabolites in vitro: formation of glucuronides by various microsomes and human UDP-glucuronosyltransferase isoforms. Molecular Nutrition and Food Research 2010, 54:1468-1476.
28. Pfeiffer E., Kommer A., Dempe J.S., Hildebrand A.A., Metzler M. Absorption and metabolism of the mycotoxin zearalenone and the growth promotor zeranol in Caco-2 cells in vitro. Molecular Nutrition and Food Research 2011, 55:560-567.
29. Prelusky D.B., Veira D.M., Trenholm H.L., Hartin K.E. Excretion profiles of the mycotoxin deoxynivalenol, following oral and intravenous administration to sheep. Fundamental and Applied Toxicology 1986, 6:356-363.
30. SCF, Scientific Committee on Food, 2000. Opinion of the scientific committee on food on fusarium toxins Part 2: Zearalenone (ZEA). SCF/CS/CNTM/MYC/22 Rev 3 Final.
31. Shephard G.S., Burger H.-M., Gambacorta L., Gong Y., Krska R., Rheeder J.P., Solfrizzo M., Srey C., Sulyok M., Visconti A., Warth B., Van der Westhuizen L. Urinary biomarkers of multiple mycotoxin exposure in rural subsistence farmers in former Transkei, South Africa. Book of Abstracts, MycoRed North America 2012, Carleton University, Ottawa, Canada.
32. Sulyok M., Krska R., Schuhmacher R. A liquid chromatography/tandem mass spectrometric multi-mycotoxin method for the quantification of 87 analytes and its application to semi-quantitative screening of moldy food samples. Analytical and Bioanalytical Chemistry 2007, 389:1505-1523.
33. Turner P.C. Deoxynivalenol and nivalenol occurrence and exposure assessment. World Mycotoxin Journal 2010, 3:315-321.
34. Turner P.C., Flannery B., Isitt C., Ali M., Pestka J. The role of biomarkers in evaluating human health concerns from fungal contaminants in food. Nutrition Research Reviews 2012, 25:162-179.
35. Turner P.C., Hopton R.P., White K.L., Fisher J., Cade J.E., Wild C.P. Assessment of deoxynivalenol metabolite profiles in UK adults. Food and Chemical Toxicology 2011, 49:132-135.
36. Turner P.C., Taylor E.F., White K.L.M., Cade J.E., Wild C.P. A comparison of 24 h urinary deoxynivalenol with recent v. average cereal consumption for UK adults. British Journal of Nutrition 2009, 1-4.
37. Turner P.C., White K.L., Burley V.J., Hopton R.P., Rajendram A., Fisher J., Cade J.E., Wild C.P. A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults. Biomarkers 2010, 15:553-562.
38. Uhlig S., Ivanova L., Fæste C.K. Enzyme-assisted synthesis and structural characterization of the 3-, 8- and 15-glucuronides of deoxynivalenol. Journal of Agricultural and Food Chemistry 2013, 61:2006-2012.
39. Warth B., Sulyok M., Berthiller F., Schuhmacher R., Fruhmann P., Hametner C., Adam G., Fröhlich J., Krska R. Direct quantification of deoxynivalenol glucuronide in human urine as biomarker of exposure to the Fusarium mycotoxin deoxynivalenol. Analytical and Bioanalytical Chemistry 2011, 401:195-200.
40. Warth B., Sulyok M., Fruhmann P., Berthiller F., Schuhmacher R., Hametner C., Adam G., Fröhlich J., Krska R. Assessment of human deoxynivalenol exposure using an LC-MS/MS based biomarker method. Toxicology Letters 2012, 211:85-90.
41. Warth B., Sulyok M., Fruhmann P., Mikula H., Berthiller F., Schuhmacher R., Hametner C., Abia W.A., Adam G., Fröhlich J., Krska R. Development and validation of a rapid multi-biomarker liquid chromatography/tandem mass spectrometry method to assess human exposure to mycotoxins. Rapid Communications in Mass Spectrometry 2012, 26:1533-1540.
42. Zinedine A., Soriano J.M., Moltó J.C., Mañes J. Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food and Chemical Toxicology 2007, 45:1-18.